Pancreatic Cancer Research

ResearcherUniversity of FreiburgActive in the last 2 years

Michael Quante

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8497-582X; OpenAlex author ID A5040038040. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [68Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initia… Co-author DOI 10.1007/s00259-026-07985-1↗
  2. Improvement of Gemcitabine Treatment of Pancreatic Cancer by the Addition of All- trans Retinoic Acid and Identification of Vitamin A and Pentraxin 3 as Potent… Co-author DOI 10.64898/2026.08.16.26359923↗
  3. Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testing. Co-author DOI 10.1007/s00432-025-06334-3↗
  4. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial. Co-author DOI 10.1016/j.ejca.2024.113926↗
  5. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Co-author DOI 10.3390/cancers14235926↗
  6. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer. Last author DOI 10.1172/jci.insight.141532↗
  7. [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13550-021-00808-4↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heiko Becker · 4 shared papers, 2022–2026 · strength 0.95
  2. Melanie Boerries · 2 shared papers, 2025–2026 · strength 0.47
  3. Dietrich Alexander Ruess · 2 shared papers, 2022–2026 · strength 0.42
  4. Ann-Christin Eder · 1 shared paper, 2026 · strength 0.27
  5. Martin Thomas Freitag · 1 shared paper, 2026 · strength 0.27
  6. Heike Luise Pahl · 1 shared paper, 2025 · strength 0.26
  7. Sarah Niessen · 1 shared paper, 2026 · strength 0.22
  8. Sophia Chikhladze · 1 shared paper, 2026 · strength 0.22
  9. Carola Focke · 1 shared paper, 2026 · strength 0.22
  10. Wilko Weichert · 2 shared papers, 2021 · strength 0.20
  11. Alexander Muckenhuber · 2 shared papers, 2021 · strength 0.20
  12. Maximilian Reichert · 2 shared papers, 2021 · strength 0.20
  13. Roland Michael Schmid · 2 shared papers, 2021 · strength 0.20
  14. Rickmer Braren · 2 shared papers, 2021 · strength 0.20
  15. Asmaa Elrakaybi · 1 shared paper, 2022 · strength 0.20
  16. Danmei Zhang · 1 shared paper, 2024 · strength 0.18
  17. Michael Haas · 1 shared paper, 2024 · strength 0.18
  18. Lena Weiss · 1 shared paper, 2024 · strength 0.18
  19. Klara Dorman · 1 shared paper, 2024 · strength 0.18
  20. Kathrin Heinrich · 1 shared paper, 2024 · strength 0.18
  21. Victoria Probst · 1 shared paper, 2024 · strength 0.18
  22. Volker Heinemann · 1 shared paper, 2024 · strength 0.18
  23. Dirk Waldschmidt · 1 shared paper, 2024 · strength 0.18
  24. Stefan Hubert Boeck · 1 shared paper, 2024 · strength 0.18
  25. Christoph Benedikt Westphalen · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.